IPO Details

AGS Health Ltd
Registered Office: B Wing 2nd Flr Prince Infocity,2 141 Kottivakkam Rajiv Gandhi,Chennai-600096, Tamil Nadu
Tel. No: +91 44 4510 4520
Fax No: NA
Email: investors@agshealth.com
Website: www.agshealth.com
Initial public offering of up to [*] equity shares of face value of Re. 1/- each ("equity shares") of AGS Health Limited (the "company" or the "company") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("offer price") aggregating up to Rs. 4800.00 crores (the "offer") comprising a fresh issue of up to [*] equity shares of face value of Re. 1/- each aggregating up to Rs. 1800.00 crores (the "fresh issue") and an offer for sale of up to [*] equity shares of face value of Re. 1/- each aggregating up to Rs. 3000.00 crores (the "offer for sale") by BCP Asia II Topco VIII Pte. Ltd. (the "promoter selling shareholder" and such shares, the "offered shares"). The company, in consultation with the brlms, may consider a pre-ipo placement of specified securities aggregating up to Rs. 360.00 crores, as may be permitted under applicable law, prior to filing of the roc. The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as Amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). The offer includes a reservation of up to [*] equity shares of face value of Re. 1/- each, aggregating up to Rs. [*] crores (constituting up to [*]% of the post-offer paid-up equity share capital of the company), for subscription by eligible employees (as defined hereinafter) ("employee reservation portion"). The offer less the employee reservation portion is hereinafter referred to as the "net offer". The company may, in consultation with the brlms, offer a discount of up to Rs. [*] of the offer price to eligible employees bidding in the employee reservation portion ("employee discount"). The offer and the net offer shall constitute [*]% and [*]% of the post-offer paid-up equity share capital of the company, respectively. The face value of equity shares is Re. 1/- each. The offer price is [*] times the face value of the equity shares. The price band, employee discount and the minimum bid lot shall be decided by the company.
Issue Money Payable On
Opens On Closes On Application Allotment
01-Jan-1970 01-Jan-1970 ₹0.00 - 0.00 ₹0.00 - 0.00
Minimum Application for shares in Nos : 0.0 Further Multiples of : 0.0
(₹ Cr) Lead Managers to the Issue
Project Cost 0.00 ICICI Securities Limited
Project Financed through Current Offer 4,800.00 J.P. Morgan India Private Limited
Post Issue Equity Share Capital 0.00 Jefferies India Private Limited
Issue Price 0.00 JM Financial Limited
Projects
Repayment and/or prepayment, in part or full, of certain borrowings availed by two wholly owned indirect Subsidiaries of the Company
General corporate purposes
Promoted By
BCP Asia II Topco VIII Pte. Lt
Listing At
BSE
NSE
Registrar To The Issue
MUFG Intime India Pvt Ltd